Covered recipient · General Payments record
ANNA BALKISUE LEE STUART MCCALL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$23,944.84
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $357.90 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $182.74 | 4 |
| Novo Nordisk AS | $72.53 | 4 |
| Lilly USA, LLC | $60.21 | 3 |
| ABBVIE INC. | $27.01 | 1 |
| DEXCOM, INC. | $15.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.01 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106175322 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.75 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104254355 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.25 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105315147 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.47 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104687506 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.27 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104680421 | CMS |
| Dexcom, Inc. | $15.41 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153281323 | CMS |
| Lilly USA, LLC | $19.69 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044288 | CMS |
| Lilly USA, LLC | $22.55 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136056198 | CMS |
| Lilly USA, LLC | $17.97 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135999607 | CMS |
| Novo Nordisk Inc | $18.96 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096904525 | CMS |
| Novo Nordisk Inc | $20.69 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097600027 | CMS |
| Novo Nordisk Inc | $17.48 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097807784 | CMS |
| Novo Nordisk Inc | $15.40 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097837522 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.